Document is current
Any future updates will be listed below
-
Authors
Brakenhoff, Timo B. http://orcid.org/0000-0003-3543-6296
Franks, Billy
Goodale, Brianna Mae
van de Wijgert, Janneke
Montes, Santiago
Veen, Duco
Fredslund, Eskild K.
Rispens, Theo
Risch, Lorenz
Dowling, Ariel V.
Folarin, Amos A.
Bruijning, Patricia
Dobson, Richard
Heikamp, Tessa
Klaver, Paul
Cronin, Maureen
Grobbee, Diederick E.
,
Denaxas, Spiros
Reitsma, Johannes B.
Simon, Christian
Kuchta, Alison
Stolk, Pieter
Downward, George
van Lier, René
Kjellberg, Jakob
Risch, Martin
Grossmann, Kirsten
Conen, David
Aeschbacher, Stefanie
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (101005177)
- License Information
-
More Information
Article History
Received: 25 March 2021
Accepted: 30 March 2021
First Online: 22 June 2021
Declarations
:
: The study was approved by the Medisch Ethische Toetsingscommissie (METC) Utrecht: reference SL/nb/21/500101 on the 27<sup>th</sup> of January, 2021.The authors certify that this trial has received ethical approval from the appropriate ethical committee as described above. Informed consent to participate in the study will be obtained from all participants.
: Not applicable
: BMG and MC are current or previous employees of Ava AG.AD is an employee of and owns stock in Takeda Pharmaceuticals.SM is an employee of Roche Diagnostics Nederland BV.AK & CS are employees of Roche Molecular Diagnostics.TBB, BF, DV, TH, PK, DEG are employees of Julius Clinical.
